Effect of prothrombin Belgrade mutation, causing antithrombin resistance, on fibrin clot properties.

Autor: Dunjic Manevski S; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Cumbo M; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Pruner I; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.; Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden., Gvozdenov M; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Tomic B; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Taxiarchis A; Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden., Antovic J; Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden., Djordjevic V; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.

Publikováno v: International journal of laboratory hematology [Int J Lab Hematol] 2024 Apr; Vol. 46 (2), pp. 329-335. Date of Electronic Publication: 2023 Nov 02.

The 3’ End Prothrombin Gene Variants in Serbian Patients with Idiopathic Thrombophilia

Autor: Aradjanski M., Djordjevic V., Pruner I., Tomic B., Gvozdenov M., Kovac M., Radojkovic D.

Publikováno v: Balkan Journal of Medical Genetics, Vol 17, Iss 2, Pp 43-48 (2014)

Thrombophilia is a multifactorial disorder that arises from the interaction of acquired and genetic risk factors. Despite the significant efforts made to understand the etiology of this disease, there are still a certain number of patients suffering

Externí odkaz: https://doaj.org/article/e1c63f7347324e0290c861ed131e9585

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Silence Speaks, but We Do Not Listen: Synonymous c.1824C>T Gene Variant in the Last Exon of the Prothrombin Gene as a New Prothrombotic Risk Factor.

Autor: Pruner I; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.; Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden., Farm M; Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden., Tomic B; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Gvozdenov M; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Kovac M; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.; Hemostasis Department, Blood Transfusion Institute of Serbia, Belgrade, Serbia., Miljic P; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.; Clinic of Hematology, University Clinical Center, Belgrade, Serbia., Soutari NMH; Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden., Antovic A; Department of Medicine, Unit of Rheumatology, Karolinska University Hospital, Stockholm, Sweden.; Academic Specialist Center, Center for Rheumatology, Stockholm Health Services, Stockholm, Sweden., Radojkovic D; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Antovic J; Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden., Djordjevic V; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.

Publikováno v: Clinical chemistry [Clin Chem] 2020 Feb 01; Vol. 66 (2), pp. 379-389.

Prothrombin 3'end Gene Variants in Patients With Sporadic Colon Adenocarcinoma.

Autor: Cumbo M; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia marijacumbo@imgge.bg.ac.rs., Tomic B; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Dunjic S; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Jovanovic T; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Gvozdenov M; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Pruner I; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Aralica G; University Hospital Dubrava, Zagreb, Croatia.; Medical School University of Zagreb, Zagreb, Croatia., Kapitanovic S; Rudjer Boskovic Institute, Zagreb, Croatia., Cacev T; Rudjer Boskovic Institute, Zagreb, Croatia., Djordjevic V; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.

Publikováno v: Anticancer research [Anticancer Res] 2019 Nov; Vol. 39 (11), pp. 6067-6071.